Establishment of a novel quantum dots‐encoded microbead‐based flow cytometric method for quantification of soluble FcεRIα in serum. Issue 7 (15th May 2017)

• Record Type: Journal Article
• Authors: Lin, Kun; Xu, Wen; Li, Wanwan; Leng, Yuankui; Wu, Weijie; Peng, Xia; Liang, Yuting; Li, Li
• Is Part Of: Cytometry. Volume 91:Issue 7(2017)
• Page Start: 686
• Page End: 693
• Publication Date: 2017-05-15
• Subjects: quantum dots‐encoded microbeads -- flow cytometry -- sFcεRIα -- cytometric bead assay -- SLE; Flow cytometry -- Periodicals; Imaging systems in biology -- Periodicals; Imaging systems in medicine -- Periodicals; Diagnostic imaging -- Periodicals; 571.605
• DOI: 10.1002/cyto.a.23128
• Languages: English
• ISSNs: 1552-4922

Abstract

Abstract: The soluble form of the transmembrane glycoprotein, FcεRIα which corresponds to the high‐affinity receptor for IgE, is found in serum. Growing evidence suggests the pathogenic role of IgE and FcεRI in systemic lupus erythematosus (SLE). The goal of this study is to develop a sensitive and standardized cytometric assay for quantification of sFcεRIα. A membrane emulsification technique was utilized to incorporate CuInS2 /ZnS quantum dots and Fe3 O4 nanoparticles into poly (styrene‐co‐maleic anhydride) microbeads. The beads were then carboxylated and coated with capture antibody monoclonal anti‐human FcεRIα. This antibody binds to FcεRIα but does not block the binding of FcεRIα to IgE. After incubation with standards or serum samples, the microbeads were incubated with excessive native human IgE, followed by incubation with Phycoerythrin (PE) conjugated anti‐human IgE. The resulting quantum dot microbeads were gated, and sFcεRIα quantification was analyzed based on PE fluorescence intensity. The method exhibited good linearity ( R 2 > 0.99), and the limit of detection was established at 0.29 ng/mL with the dynamic range of up to 200 ng/mL. The precision of the assay validated by intra‐ and inter‐assay variability met the acceptance criteria with the mean recovery falling within 80–110% of the theoretical concentration and a corresponding CV < 20%. We tested 149 serum samples which 89 were from SLE patients and 60 were from healthy volunteers. For the first time, we detected an increased sFcεRIα level in the serum of SLE patients, which was confirmed by a commercial ELISA kit. Compared to ELISA, this novel method is more sensitive and efficient. It allows for the simple comparative analysis of sFcεRIα levels in health and disease. © 2017 International Society for Advancement of Cytometry